MolecuLight Launches i:X® Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting

July 9, 2020 -New Disposable Sleeve allows MolecuLight i:X to Be Used in Operating Rooms (for skin grafts and skin substitutes), in Covid-19 Wards and in MRSA Isolation Wards

Toronto, CANADA – (July 9, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the

MolecuLight i:X® Platform Available to 9,000 Healthcare Facilities Through MAGNET GROUP GPO

June 15, 2020 -Leading GPO Accepts MolecuLight i:X Point-of-Care Device for Detection of Bacteria and Digital Wound Measurement for its National Membership

Toronto, CANADA – (June 15, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform to

MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X® Procedure for Bacterial Imaging using Fluorescence

June 11, 2020 -New Code Enables Facility Reimbursement to Hospital Outpatient Centers Performing MolecuLight’s Procedure Benefiting Wound Care Patients

Toronto, CANADA – (June 11, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces that the Centers for Medicare & Medicaid Services (CMS) has

MolecuLight Announces Industry Partnership and Virtual Exhibit of its MolecuLight i:X® Platform at WoundCon™ 2020, the Largest Conference for Wound Care

April 1, 2020 -Novel Virtual Conference Attracts 10,000 Wound Care Professionals as Alternate to Live Medical Conferences Given Travel Challenges Due to Covid-19

Toronto, CANADA and Atlantic Beach, USA – (April 1, 2020) MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces its Sponsorship and participation

First Published Study to Report In Vitro Detection of Fluorescence from Bacteria in Biofilm with Point-of-care Wound Imaging Device

March 3, 2020 -In Vitro Study Demonstrates Detectable Red Fluorescence from 88% of Planktonic and Biofilm Wound Pathogens when Imaged by the MolecuLight i:X® Imaging Device

Toronto, CANADA – (March 3, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announces the publication of  “… Read More

New MolecuLight i:X® Upgrade Enables Faster, More Accurate Digital Wound Measurement

February 20, 2020 -i:X Platform’s Precise Wound Measurement, along with Fluorescence Imaging, for More Accurate Detection and Ongoing Documentation of Wounds

Toronto, CANADA – (February 20, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, released a significant upgrade to its i:X digital wound measurement

American Medical Association Issues Category lll CPT Code for Real-time Fluorescence Wound Imaging

February 13, 2020 -

Reimbursement Pathway Established for MolecuLight’s i:X Procedure in Wound Care

TORONTO, Canada – (February 13, 2020) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announced that the American Medical Association (AMA) has issued two new CPT category lll codes to enable a

University Hospitals Ahuja Medical Center Physician First in Ohio to Use Wound Care Imaging Device in Clinical Setting

February 11, 2020 -

Portable MolecuLight i:X allows for imaging of harmful bacteria invisible to human eye

University Hospitals Ahuja Medical Center (UH) is the first clinical setting in Ohio using special technology to identify harmful bacteria, leading to healing for patients suffering from chronic wounds.

Windy Cole, DPM, Medical Director of the UH